Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Bird flu, special controls: Influenza A subtype tests and reagents are officially Class II medical devices following the March 22 release of a final rule and special controls 1guidance document detailing the 510(k) requirements for such products. The Centers for Disease Control & Prevention won clearance for the first rapid H5 subtype test to help identify avian flu cases through an expedited de novo 510(k) application in February (2"The Gray Sheet" Feb. 6, 2006, p. 11). Several firms are developing avian flu tests, including Toronto-based Tm Bioscience...